Low expression of mixed lineage kinase domain-like protein is associated with poor prognosis in ovarian cancer patients

BACKGROUND: Mixed lineage kinase domain-like protein (MLKL) was initially identified as a key receptor interacting protein 3 downstream component of tumor-necrosis-factor-induced necrosis. In this study, we characterized the expression of MLKL in ovarian carcinomas and evaluated the prognostic value...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Ling, Peng, Kuan, Liu, Yizhi, Xiong, Jing, Zhu, Fu-fan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817086/
https://www.ncbi.nlm.nih.gov/pubmed/24204164
http://dx.doi.org/10.2147/OTT.S52805

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817086/
https://www.ncbi.nlm.nih.gov/pubmed/24204164
http://dx.doi.org/10.2147/OTT.S52805

Ejemplares similares